One-Year Results of Intravitreal Ranibizumab with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

Publisher： Karger

E-ISSN： 1423-0267|226|3|119-126

ISSN： 0030-3755

Source： Ophthalmologica, Vol.226, Iss.3, 2011-07, pp. : 119-126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Two-Year Results of Photodynamic Therapy Combined with Intravitreal Anti-Vascular Endothelial Growth Factor for Polypoidal Choroidal Vasculopathy

By  

Ophthalmologica, Vol. 226, Iss. 4, 2011-09 ,pp. : 205-213

Karger

Access to resources Recommend Favorite

Polypoidal Choroidal Vasculopathy Exudation and Hemorrhage: Results of Monthly Ranibizumab Therapy at One Year

By  

Ophthalmologica, Vol. 231, Iss. 2, 2013-10 ,pp. : 94-102

Karger

Access to resources Recommend Favorite

One-Year Outcomes following Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in Japanese Patients: The APOLLO Study

By  

Ophthalmologica, Vol. 238, Iss. 3, 2017-07 ,pp. : 163-171

Karger

Access to resources Recommend Favorite

Photodynamic Therapy with Verteporfin for Polypoidal Choroidal Vasculopathy of the Macula

By  

Ophthalmologica, Vol. 218, Iss. 3, 2004-04 ,pp. : 193-201

Karger

Access to resources Recommend Favorite

Photodynamic Therapy Combined with Intravitreal Injection of Vascular Endothelial Growth Factor Antibody for Polypoidal Choroidal Vasculopathy

By  

Ophthalmologica, Vol. 225, Iss. 3, 2011-01 ,pp. : 169-175

Karger

Access to resources Recommend Favorite